Corticosteroid therapy for critically ill patients with the Middle East Respiratory Syndrome.

<h4>Rationale</h4> <p>Corticosteroid therapy is commonly used among critically ill patients with the Middle East Respiratory Syndrome (MERS), but its impact on outcomes is uncertain. Analyses of observational studies often do not account for patients’ clinical condition at the tim...

Full description

Bibliographic Details
Main Authors:	Arabi, Y, Mandourah, Y, Al-Hameed, F, Sindi, A, Al Mekhlafi, G, Hussein, M, Jose, J, Pinto, R, Al-Omari, A, Kharaba, A, Almotairi, A, Al Khatib, K, Alraddadi, B, Shalhoub, S, Abdulmomen, A, Qushmaq, I, Mady, A, Solaiman, O, Al-Aithan, A, Al-Raddadi, R, Ragab, A, Balkhy, H, Al Harthy, A, Deeb, A, Al Mutairi, H, Al-Dawood, A, Merson, L, Hayden, F, Fowler, R
Format:	Journal article
Language:	English
Published:	American Thoracic Society Journals 2017

Corticosteroid therapy for critically ill patients with the Middle East Respiratory Syndrome.

Similar Items